CVR number 44045702
Industry 86.2300 Dental practice activities

Tandlæge Nasser Residegan ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 0.0% 6.2%  
Credit score (0-100)  0 0 0 0 38  
Credit rating  N/A N/A N/A N/A BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 0.0 3,523  
EBITDA  0.0 0.0 0.0 0.0 1,933  
EBIT  0.0 0.0 0.0 0.0 1,802  
Pre-tax profit (PTP)  0.0 0.0 0.0 0.0 1,801.5  
Net earnings  0.0 0.0 0.0 0.0 1,392.3  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 0.0 1,801  
 
See the entire income statement

Balance sheet (kDKK) 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Tangible assets total  0.0 0.0 0.0 0.0 645  
Shareholders equity total  0.0 0.0 0.0 0.0 1,432  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 0.0 1,919  
Net Debt  0.0 0.0 0.0 0.0 -766  
 
See the entire balance sheet

Volume 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 0.0 3,523  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 0 1,919  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 0.0%  
Added value  0.0 0.0 0.0 0.0 1,932.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 942  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 0.0 1.0  

Profitability 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 0.0% 51.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 0.0% 94.0%  
ROI %  0.0% 0.0% 0.0% 0.0% 123.7%  
ROE %  0.0% 0.0% 0.0% 0.0% 97.2%  

Solidity 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Equity ratio %  0.0% 0.0% 0.0% 0.0% 74.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% -39.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Quick Ratio  0.0 0.0 0.0 0.0 5.6  
Current Ratio  0.0 0.0 0.0 0.0 5.6  
Cash and cash equivalent  0.0 0.0 0.0 0.0 766.4  

Capital use efficiency 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 0.0 682.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
N/A
2021
N/A
2022
N/A
2023
N/A
2024
2024/8
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 966  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 966  
EBIT / employee  0 0 0 0 901  
Net earnings / employee  0 0 0 0 696